Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J. Sin DD, et al. Among authors: lindmark b. Thorax. 2005 Dec;60(12):992-7. doi: 10.1136/thx.2005.045385. Epub 2005 Oct 14. Thorax. 2005. PMID: 16227327 Free PMC article.
Cardiac risks with beta agonists.
Lindmark B. Lindmark B. Thorax. 1998 Dec;53(12):1094-5. doi: 10.1136/thx.53.12.1094. Thorax. 1998. PMID: 10195086 Free PMC article. No abstract available.
Beta2 agonists and heart failure.
Lindmark B, Ottosson A. Lindmark B, et al. Lancet. 1998 Nov 21;352(9141):1709-10. doi: 10.1016/S0140-6736(05)61488-2. Lancet. 1998. PMID: 9853469 No abstract available.
Developments for a growing Japanese patient population: facilitating new technologies for future health care.
Kato H, Nishimura T, Ikeda N, Yamada T, Kondo T, Saijo N, Nishio K, Fujimoto J, Nomura M, Oda Y, Lindmark B, Maniwa J, Hibino H, Unno M, Ito T, Sawa Y, Tojo H, Egawa S, Edula G, Lopez M, Wigmore M, Inase N, Yoshizawa Y, Nomura F, Marko-Varga G. Kato H, et al. Among authors: lindmark b. J Proteomics. 2011 May 16;74(6):759-64. doi: 10.1016/j.jprot.2010.12.006. Epub 2010 Dec 22. J Proteomics. 2011. PMID: 21184850
Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.
Haggag AZ, Xu J, Butcher L, Pagnussat S, Davies G, Lundqvist S, Wang W, Van Zuydam N, Nelander K, Jha A, Yu H, Boianelli A, Lindmark B, Ollerstam A, Sun X, Wang F, Pan X, Liu H, Chen W, Xu J, Wallenius K, Zhou J. Haggag AZ, et al. Among authors: lindmark b. Diabetes Obes Metab. 2024 Nov 4. doi: 10.1111/dom.16047. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39495140
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants.
Li XQ, Lindmark B, Amilon C, Samuelsson K, Weidolf L, Nelander K, Knöchel J, Heijer M, Bragg RA, Gränfors M, Lindstedt EL, Sidhu S, Garkaviy P, Ericsson H. Li XQ, et al. Among authors: lindmark b. Pharmacol Res Perspect. 2024 Oct;12(5):e70029. doi: 10.1002/prp2.70029. Pharmacol Res Perspect. 2024. PMID: 39400479 Free PMC article.
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment.
Aslanis V, Gray M, Slack RJ, Zetterberg FR, Tonev D, Phung D, Smith B, Jacoby B, Schambye H, Krastev Z, Ungell AL, Lindmark B. Aslanis V, et al. Among authors: lindmark b. Clin Drug Investig. 2024 Oct;44(10):773-787. doi: 10.1007/s40261-024-01395-7. Epub 2024 Oct 2. Clin Drug Investig. 2024. PMID: 39358661 Clinical Trial.
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).
Aslanis V, Abd-Elaziz K, Slack RJ, Brinch A, Gravelle L, Morley W, Phung D, Herman K, Holyer I, Poulsen KK, Dogterom P, Tantawi S, Zetterberg FR, Jacoby B, Schambye H, Lindmark B. Aslanis V, et al. Among authors: lindmark b. Cancer Chemother Pharmacol. 2024 Nov;94(5):707-720. doi: 10.1007/s00280-024-04710-3. Epub 2024 Aug 21. Cancer Chemother Pharmacol. 2024. PMID: 39167148 Clinical Trial.
Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
Lindmark B, Li XQ, Bhattacharya C, Housler G, Heijer M, Bragg RA, Gränfors M, Pelay-Gimeno M, Vaes WHJ, Menakuru S, Pizzato PE, Ericsson H, Johansson S. Lindmark B, et al. Drug Metab Dispos. 2023 Aug;51(8):995-1004. doi: 10.1124/dmd.122.001240. Epub 2023 Jul 5. Drug Metab Dispos. 2023. PMID: 37407094
110 results